Syncona
Londonsynconaltd.com
Overview
Syncona is a London-based, publicly traded healthcare investment firm focused on founding, building, and scaling global life science companies to deliver transformational treatments for patients in areas of high unmet need.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Re-Aim Therapeutics | May 2026 | Seed | Lead |
| ALTx Therapeutics | Feb 2026 | Accelerator | Co-investor |
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| Apini Therapeutics | Jun 2025 | Seed | Co-investor |
| Apini Therapeutics | Nov 2024 | Accelerator | Lead |
Key People
Elisa Petris
Managing Partner
Roel Bulthuis
Managing Partner
Ben Woolven
Business Strategy And Operations Partner
Hitesh Thakrar
Partner
Gonzalo Garcia
Principal
Alex Hamilton
Investor
Michael Kyriakides
Life Sciences Company Builder And Investor
Usman Sherani
Investor Relations Corporate Communications And Sustainability Associate
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
